Get the Stockscreener App
298.50
1.19%
3.51
After Hours:
298.50
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Ligand Pharmaceuticals Inc Stock (LGND) Forecast
The Ligand Pharmaceuticals Inc (LGND) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $318.34, representing a +6.65% increase from the current price of $298.50. The highest analyst price target is $330.43, and the lowest is $306.25.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LGND Price Target
Average 292.98
(-1.85% Downside)
Is Ligand Pharmaceuticals Inc (LGND) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 50.63 | Neutral |
| STOCH(9,6) | 58.04 | Neutral |
| STOCHRSI(14) | 12.78 | Buy |
| MACD(12,26) | 2.4212 | Sell |
| ADX(14) | 13.84 | Neutral |
| William %R | -52.78 | Neutral |
| CCI(14) | -25.74 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
300.49
Sell
|
300.40
Sell
|
| MA20 |
300.77
Sell
|
298.91
Sell
|
| MA50 |
292.54
Buy
|
293.64
Buy
|
| MA100 |
286.76
Buy
|
280.70
Buy
|
| MA200 |
246.42
Buy
|
252.62
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, LGND could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 5 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on LGND, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 50.63 indicates that LGND is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 58.04 indicates that LGND is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 12.78 indicates that LGND is oversold. This suggests that LGND price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 13.84 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -25.74 indicates that LGND is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term LGND price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Ligand Pharmaceuticals Inc financial reports and earnings history, Ligand Pharmaceuticals Inc (LGND) stock could reach $373.02 by 2030, $739.34 by 2040 and $993.36 by 2050. See the projected annual prices until 2050 of the Ligand Pharmaceuticals Inc stock below:
- Ligand Pharmaceuticals Inc (LGND) is expected to reach an average price of $564.27 in 2035, with a high prediction of $565.34 and a low estimate of $550.92. This indicates an $89.04% rise from the last recorded price of $298.50.
- Ligand Pharmaceuticals Inc (LGND) stock is projected to chart a bullish course in 2040, with an average price target of $736.31, representing an $146.67% surge from its current level. The forecast ranges from a conservative $733.33 to a sky-high $739.34.
- Our analysts predict Ligand Pharmaceuticals Inc (LGND) to jump 191.27% by 2045, soaring from $867.20 to an average price of $869.45, potentially reaching $877.37. While $867.20 is the low estimate, the potential upside is significant.
- Ligand Pharmaceuticals Inc (LGND) stock is expected to climb by 2050, reaching an average of $992.81, a $232.60% jump from its current level. However, a wide range of estimates exists, with high and low targets of $993.36 and $973.81, respectively, highlighting the market's uncertainty.
Ligand Pharmaceuticals Inc Stock (LGND) Year by Year Forecast
Ligand Pharmaceuticals Inc Stock (LGND) Price Forecast for 2026
The predicted value for Ligand Pharmaceuticals Inc (LGND) in 2026 is set at an average of $253.16. Estimates vary from a peak of $330.43 to a trough of $175.89, indicating an -15.19% surge from the present price of $298.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $324.25 | $306.25 | $330.43 | +8.63% |
| December, 2026 | $326.01 | $299.53 | $329.32 | +9.22% |
Ligand Pharmaceuticals Inc Stock (LGND) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Ligand Pharmaceuticals Inc (LGND) is $292.69, with a high forecast of $330.29 and a low forecast of $255.10. This indicates an -1.94% decrease from the last price of $298.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $281.51 | $278.74 | $330.29 | -5.69% |
| February, 2027 | $290.38 | $278.97 | $298.34 | -2.72% |
| March, 2027 | $276.00 | $259.57 | $295.17 | -7.54% |
| April, 2027 | $292.51 | $273.88 | $296.49 | -2.01% |
| May, 2027 | $267.06 | $265.35 | $294.46 | -10.53% |
| June, 2027 | $269.99 | $257.00 | $271.63 | -9.55% |
| July, 2027 | $272.88 | $255.52 | $274.42 | -8.58% |
| August, 2027 | $277.97 | $269.73 | $284.07 | -6.88% |
| September, 2027 | $291.90 | $276.21 | $298.20 | -2.21% |
| October, 2027 | $287.80 | $280.71 | $294.62 | -3.58% |
| November, 2027 | $284.32 | $270.18 | $291.85 | -4.75% |
| December, 2027 | $259.33 | $255.10 | $292.36 | -13.12% |
Ligand Pharmaceuticals Inc Stock (LGND) Price Forecast for 2028
In 2028, Ligand Pharmaceuticals Inc (LGND) is projected to reach an average price of $280.01, with a high projection of $301.15 and a low estimate of $258.87. This indicates an -6.19% fall from the last price of $298.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $273.11 | $258.87 | $282.53 | -8.51% |
| February, 2028 | $269.75 | $262.63 | $274.14 | -9.63% |
| March, 2028 | $275.74 | $268.32 | $283.44 | -7.62% |
| April, 2028 | $281.62 | $274.12 | $282.55 | -5.66% |
| May, 2028 | $283.23 | $277.70 | $288.20 | -5.11% |
| June, 2028 | $287.91 | $279.14 | $290.09 | -3.55% |
| July, 2028 | $291.05 | $287.67 | $301.15 | -2.50% |
| August, 2028 | $293.00 | $286.82 | $296.05 | -1.84% |
| September, 2028 | $291.35 | $290.86 | $300.50 | -2.40% |
| October, 2028 | $291.61 | $288.68 | $293.82 | -2.31% |
| November, 2028 | $293.09 | $291.04 | $296.33 | -1.81% |
| December, 2028 | $288.90 | $288.51 | $295.43 | -3.22% |
Ligand Pharmaceuticals Inc Stock (LGND) Price Forecast for 2029
The 2029 price forecast for Ligand Pharmaceuticals Inc Stock (LGND) is $327.69 on average, with a high prediction of $373.19 and a low estimate of $282.19. This represents an +9.78% increase from the previous price of $298.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $282.52 | $282.19 | $293.18 | -5.35% |
| February, 2029 | $293.27 | $283.36 | $293.80 | -1.75% |
| March, 2029 | $299.77 | $293.10 | $300.25 | +0.42% |
| April, 2029 | $313.67 | $298.85 | $316.22 | +5.08% |
| May, 2029 | $318.11 | $309.23 | $319.33 | +6.57% |
| June, 2029 | $325.42 | $315.40 | $340.64 | +9.02% |
| July, 2029 | $322.29 | $317.44 | $327.63 | +7.97% |
| August, 2029 | $322.26 | $319.41 | $332.59 | +7.96% |
| September, 2029 | $340.25 | $321.95 | $341.72 | +13.99% |
| October, 2029 | $336.71 | $334.12 | $344.80 | +12.80% |
| November, 2029 | $359.58 | $335.47 | $361.74 | +20.46% |
| December, 2029 | $365.15 | $352.61 | $373.19 | +22.33% |
Ligand Pharmaceuticals Inc Stock (LGND) Price Forecast for 2030
Ligand Pharmaceuticals Inc Stock (LGND) is expected to reach an average price of $388.21 in 2030, with a high forecast of $412.77 and a low forecast of $363.65. This signifies an +30.05% surge from the last price of $298.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $370.21 | $363.71 | $373.02 | +24.02% |
| February, 2030 | $372.72 | $363.65 | $373.83 | +24.87% |
| March, 2030 | $376.14 | $367.46 | $385.97 | +26.01% |
| April, 2030 | $395.04 | $378.12 | $401.59 | +32.34% |
| May, 2030 | $385.26 | $384.26 | $402.05 | +29.06% |
| June, 2030 | $390.46 | $381.36 | $391.76 | +30.81% |
| July, 2030 | $402.36 | $391.49 | $404.71 | +34.79% |
| August, 2030 | $392.34 | $387.00 | $408.11 | +31.44% |
| September, 2030 | $392.28 | $380.27 | $397.43 | +31.42% |
| October, 2030 | $394.29 | $389.05 | $401.11 | +32.09% |
| November, 2030 | $398.30 | $390.35 | $399.64 | +33.44% |
| December, 2030 | $410.02 | $396.37 | $412.77 | +37.36% |
1.45%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):